Page results
-
This step-by-step guide explains how you can give yourself an injection of bortezomib at home.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
If you need an assessment by a midwife or doctor that is outside of your routine antenatal appointments you will be invited to attend the Maternal and Fetal Assessment Unit (MFAU).
-
Patient information leaflet for patients suffering form long COVID who are experiencing breathlessness or changes in their breathing pattern.
-
A summary of a twitter chat hosted by the Macmillan Support and Information Service on cancer-related fatigue with advice about to manage it.
-
This patient information includes different relaxation techniques which patients being seen by the Post-COVID Service team may find useful.
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
-
This page explains what FACETS is and how it can help you.
-
An evaluation of temporary changes to children and young people’s services in North Central London (NCL) in the autumn and winter of 2020/21 has been published.
-
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
File results
-
FOI/2022/0674 - Maternity locum staffing
-
FOI/2022/0675 - Drug treatment for Paediatric patients (ages 0-16)
-
FOI/2022/0677 - Documents relating to the lift being out of order (RLHIM Lift 2 by reception)
-
FOI/2022/0679 - Theatre management, AA's and ODPs
-
FOI/2022/0681 - Deep brain stimulation procedure
-
FOI/2022/0686 - Breast cancer patients
-
FOI/2022/0692 - Respiratory diagnostic equipment
-
FOI/2022/0696 - Trust complaints policy and discrimination and diversity policy
-
FOI/2022/0704 - Elective operations cancelled for non-clinical reasons
-
FOI/2022/0705 - Head/ neck and urothelial cancer treatment